Is CSBR stock a buy right now?
1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Champions Oncology in the last year. There are currently 1 buy ra...
When is Champions Oncology's next earnings date?
Champions Oncology is scheduled to release its next quarterly earnings announcement on Thursday, July 28th 2022. View our earnings forecast for Ch...
How were Champions Oncology's earnings last quarter?
Champions Oncology, Inc. (NASDAQ:CSBR) announced its earnings results on Tuesday, March, 15th. The biotechnology company reported $0.05 earnings pe...
What guidance has Champions Oncology issued on next quarter's earnings?
Champions Oncology updated its FY 2022 earnings guidance on Tuesday, April, 12th. The company provided EPS guidance of for the period. The company...
Who are Champions Oncology's key executives?
Champions Oncology's management team includes the following people: Ronnie Morris , President Chief Executive Officer & Director David Barry Mill...
What is Ronnie Morris' approval rating as Champions Oncology's CEO?
8 employees have rated Champions Oncology CEO Ronnie Morris on Glassdoor.com . Ronnie Morris has an approval rating of 50% among Champions Oncolog...
Who are some of Champions Oncology's key competitors?
Some companies that are related to Champions Oncology include Monte Rosa Therapeutics (GLUE) , Mesoblast (MESO) , MeiraGTx (MGTX) , Adagio Ther...
What other stocks do shareholders of Champions Oncology own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Champions Oncology investors own include Gilead Sciences (...
What is Champions Oncology's stock symbol?
Champions Oncology trades on the NASDAQ under the ticker symbol "CSBR."
What is the CSBR symbol?
What is MarketBeat community ratings?
Champions Oncology trades on the NASDAQ under the ticker symbol "CSBR."
Is Champions Oncology a buy or sell company?
MarketBeat's community ratings are surveys of what our community members think about Champions Oncology and other stocks. Vote “Outperform” if you believe CSBR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CSBR will underperform the S&P 500 over the long term. You may vote once every thirty days.
Does Champions Oncology pay dividends?
Champions Oncology has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.